Fiber intake associates with increased treatment response in patients with multiple myeloma along with changes in gut microbiome.
Saved in:
| Title: | Fiber intake associates with increased treatment response in patients with multiple myeloma along with changes in gut microbiome. |
|---|---|
| Authors: | Sester LS; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Galeeva I; Department of Internal Medicine I and M3 Research Institute, University Clinic Tuebingen, Tuebingen, Germany.; Cluster of Excellence Controlling Microbes to Fight Infections, University of Tuebingen, Tuebingen, Germany., de Castilhos J; Department of Internal Medicine I and M3 Research Institute, University Clinic Tuebingen, Tuebingen, Germany.; Cluster of Excellence Controlling Microbes to Fight Infections, University of Tuebingen, Tuebingen, Germany., Borisov V; Department of Internal Medicine I and M3 Research Institute, University Clinic Tuebingen, Tuebingen, Germany.; Cluster of Excellence Controlling Microbes to Fight Infections, University of Tuebingen, Tuebingen, Germany., Gambihler AK; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Kilian M; German Cancer Consortium Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany.; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA., Vonhören D; German Cancer Consortium Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany.; Department of Neurology, The Mannheim Center for Translational Neuroscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Friedrich MJ; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Broad Institute of MIT and Harvard, Cambridge, MA., Poschet G; Metabolomics Core Technology Platform, Center for Organismal Studies, Heidelberg University, Heidelberg, Germany., Steiger S; Division of Chromatin Networks, German Cancer Research Center and BioQuant, Heidelberg, Germany., Chechenina A; Department of Internal Medicine I and M3 Research Institute, University Clinic Tuebingen, Tuebingen, Germany.; Cluster of Excellence Controlling Microbes to Fight Infections, University of Tuebingen, Tuebingen, Germany., Lettau K; Department of Internal Medicine I and M3 Research Institute, University Clinic Tuebingen, Tuebingen, Germany.; Cluster of Excellence Controlling Microbes to Fight Infections, University of Tuebingen, Tuebingen, Germany., Kohlberger CP; Department of Internal Medicine I and M3 Research Institute, University Clinic Tuebingen, Tuebingen, Germany.; Cluster of Excellence Controlling Microbes to Fight Infections, University of Tuebingen, Tuebingen, Germany., Prokoph N; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Frenking J; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., John L; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Huhn S; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Reichert P; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Mai EK; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Rippe K; Division of Chromatin Networks, German Cancer Research Center and BioQuant, Heidelberg, Germany., Sauer S; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Müller-Tidow C; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Weinhold N; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Platten M; German Cancer Consortium Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany.; Department of Neurology, The Mannheim Center for Translational Neuroscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; German Cancer Research Center Hector Cancer Institute, University Medical Center Mannheim, Mannheim, Germany.; Helmholtz Institute of Translational Oncology, Mainz, Germany.; Immune Monitoring Unit, National Center for Tumor Diseases, Heidelberg, Germany., Goldschmidt H; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; National Center for Tumor Diseases, Heidelberg, Germany., Raab MS; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Stein-Thoeringer CK; Department of Internal Medicine I and M3 Research Institute, University Clinic Tuebingen, Tuebingen, Germany.; Cluster of Excellence Controlling Microbes to Fight Infections, University of Tuebingen, Tuebingen, Germany.; German Center for Infectious Diseases, Tuebingen, Germany. |
| Source: | Blood advances [Blood Adv] 2026 May 12; Vol. 10 (9), pp. 3088-3093. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41734379 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Fiber intake associates with increased treatment response in patients with multiple myeloma along with changes in gut microbiome. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sester+LS%22">Sester LS</searchLink>; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Galeeva+I%22">Galeeva I</searchLink>; Department of Internal Medicine I and M3 Research Institute, University Clinic Tuebingen, Tuebingen, Germany.; Cluster of Excellence Controlling Microbes to Fight Infections, University of Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22de+Castilhos+J%22">de Castilhos J</searchLink>; Department of Internal Medicine I and M3 Research Institute, University Clinic Tuebingen, Tuebingen, Germany.; Cluster of Excellence Controlling Microbes to Fight Infections, University of Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Borisov+V%22">Borisov V</searchLink>; Department of Internal Medicine I and M3 Research Institute, University Clinic Tuebingen, Tuebingen, Germany.; Cluster of Excellence Controlling Microbes to Fight Infections, University of Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Gambihler+AK%22">Gambihler AK</searchLink>; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Kilian+M%22">Kilian M</searchLink>; German Cancer Consortium Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany.; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Vonhören+D%22">Vonhören D</searchLink>; German Cancer Consortium Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany.; Department of Neurology, The Mannheim Center for Translational Neuroscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Friedrich+MJ%22">Friedrich MJ</searchLink>; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Broad Institute of MIT and Harvard, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Poschet+G%22">Poschet G</searchLink>; Metabolomics Core Technology Platform, Center for Organismal Studies, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Steiger+S%22">Steiger S</searchLink>; Division of Chromatin Networks, German Cancer Research Center and BioQuant, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Chechenina+A%22">Chechenina A</searchLink>; Department of Internal Medicine I and M3 Research Institute, University Clinic Tuebingen, Tuebingen, Germany.; Cluster of Excellence Controlling Microbes to Fight Infections, University of Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Lettau+K%22">Lettau K</searchLink>; Department of Internal Medicine I and M3 Research Institute, University Clinic Tuebingen, Tuebingen, Germany.; Cluster of Excellence Controlling Microbes to Fight Infections, University of Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Kohlberger+CP%22">Kohlberger CP</searchLink>; Department of Internal Medicine I and M3 Research Institute, University Clinic Tuebingen, Tuebingen, Germany.; Cluster of Excellence Controlling Microbes to Fight Infections, University of Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Prokoph+N%22">Prokoph N</searchLink>; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Frenking+J%22">Frenking J</searchLink>; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22John+L%22">John L</searchLink>; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Huhn+S%22">Huhn S</searchLink>; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Reichert+P%22">Reichert P</searchLink>; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Mai+EK%22">Mai EK</searchLink>; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Rippe+K%22">Rippe K</searchLink>; Division of Chromatin Networks, German Cancer Research Center and BioQuant, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Sauer+S%22">Sauer S</searchLink>; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Müller-Tidow+C%22">Müller-Tidow C</searchLink>; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Weinhold+N%22">Weinhold N</searchLink>; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Platten+M%22">Platten M</searchLink>; German Cancer Consortium Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany.; Department of Neurology, The Mannheim Center for Translational Neuroscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; German Cancer Research Center Hector Cancer Institute, University Medical Center Mannheim, Mannheim, Germany.; Helmholtz Institute of Translational Oncology, Mainz, Germany.; Immune Monitoring Unit, National Center for Tumor Diseases, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Goldschmidt+H%22">Goldschmidt H</searchLink>; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; National Center for Tumor Diseases, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Raab+MS%22">Raab MS</searchLink>; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Stein-Thoeringer+CK%22">Stein-Thoeringer CK</searchLink>; Department of Internal Medicine I and M3 Research Institute, University Clinic Tuebingen, Tuebingen, Germany.; Cluster of Excellence Controlling Microbes to Fight Infections, University of Tuebingen, Tuebingen, Germany.; German Center for Infectious Diseases, Tuebingen, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2026 May 12; Vol. 10 (9), pp. 3088-3093. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41734379 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/bloodadvances.2025018598 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3088 Titles: – TitleFull: Fiber intake associates with increased treatment response in patients with multiple myeloma along with changes in gut microbiome. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sester LS – PersonEntity: Name: NameFull: Galeeva I – PersonEntity: Name: NameFull: de Castilhos J – PersonEntity: Name: NameFull: Borisov V – PersonEntity: Name: NameFull: Gambihler AK – PersonEntity: Name: NameFull: Kilian M – PersonEntity: Name: NameFull: Vonhören D – PersonEntity: Name: NameFull: Friedrich MJ – PersonEntity: Name: NameFull: Poschet G – PersonEntity: Name: NameFull: Steiger S – PersonEntity: Name: NameFull: Chechenina A – PersonEntity: Name: NameFull: Lettau K – PersonEntity: Name: NameFull: Kohlberger CP – PersonEntity: Name: NameFull: Prokoph N – PersonEntity: Name: NameFull: Frenking J – PersonEntity: Name: NameFull: John L – PersonEntity: Name: NameFull: Huhn S – PersonEntity: Name: NameFull: Reichert P – PersonEntity: Name: NameFull: Mai EK – PersonEntity: Name: NameFull: Rippe K – PersonEntity: Name: NameFull: Sauer S – PersonEntity: Name: NameFull: Müller-Tidow C – PersonEntity: Name: NameFull: Weinhold N – PersonEntity: Name: NameFull: Platten M – PersonEntity: Name: NameFull: Goldschmidt H – PersonEntity: Name: NameFull: Raab MS – PersonEntity: Name: NameFull: Stein-Thoeringer CK IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 05 Text: 2026 May 12 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2473-9537 Numbering: – Type: volume Value: 10 – Type: issue Value: 9 Titles: – TitleFull: Blood advances Type: main |
| ResultId | 1 |